138 related articles for article (PubMed ID: 21081199)
1. Pharmacology of 5-HT6 receptors--Part 1. Preface.
Borsini F
Int Rev Neurobiol; 2010; 94():xi-xii. PubMed ID: 21081199
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of 5-HT6 receptor ligands.
Mancinelli A
Int Rev Neurobiol; 2010; 94():153-72. PubMed ID: 21081206
[No Abstract] [Full Text] [Related]
3. Electrophysiology of 5-HT6 receptors.
Tassone A; Madeo G; Sciamanna G; Pisani A; Bonsi P
Int Rev Neurobiol; 2010; 94():111-28. PubMed ID: 21081204
[No Abstract] [Full Text] [Related]
4. 5-HT6 medicinal chemistry.
Liu KG; Robichaud AJ
Int Rev Neurobiol; 2010; 94():1-34. PubMed ID: 21081200
[No Abstract] [Full Text] [Related]
5. Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement.
Di Chiara G; Valentini V; Fenu S
Int Rev Neurobiol; 2011; 96():111-39. PubMed ID: 21329786
[No Abstract] [Full Text] [Related]
6. Patents.
Ruiz NV; Oranias Olsina G
Int Rev Neurobiol; 2010; 94():35-66. PubMed ID: 21081201
[No Abstract] [Full Text] [Related]
7. 5-HT6 receptor ligands as antidementia drugs.
Mitchell ES
Int Rev Neurobiol; 2011; 96():163-87. PubMed ID: 21329788
[No Abstract] [Full Text] [Related]
8. 5-HT6 receptor characterization.
Riccioni T
Int Rev Neurobiol; 2010; 94():67-88. PubMed ID: 21081202
[No Abstract] [Full Text] [Related]
9. Other 5-HT6 receptor-mediated effects.
Borsini F
Int Rev Neurobiol; 2011; 96():189-91. PubMed ID: 21329789
[No Abstract] [Full Text] [Related]
10. The central role of 5-HT6 receptors in modulating brain neurochemistry.
Dawson LA
Int Rev Neurobiol; 2011; 96():1-26. PubMed ID: 21329782
[No Abstract] [Full Text] [Related]
11. Graham Johnston: bringing success to neuroscience through medicinal chemistry. Preface.
Beart PM; Balcar VJ
Neurochem Res; 2009 Oct; 34(10):1696-7. PubMed ID: 19484383
[No Abstract] [Full Text] [Related]
12. 5-HT6 pharmacology inconsistencies.
Borsini F; Bordi F; Riccioni T
Pharmacol Biochem Behav; 2011 Apr; 98(2):169-72. PubMed ID: 21192969
[TBL] [Abstract][Full Text] [Related]
13. 5-HT6 receptor signal transduction second messenger systems.
Codony X; Burgueño J; Ramírez MJ; Vela JM
Int Rev Neurobiol; 2010; 94():89-110. PubMed ID: 21081203
[No Abstract] [Full Text] [Related]
14. Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.
Brioschi AM; Calderoni S; Zara GP; Priano L; Gasco MR; Mauro A
Prog Brain Res; 2009; 180():193-223. PubMed ID: 20302836
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitters of the brain: serotonin, noradrenaline (norepinephrine), and dopamine.
Blows WT
J Neurosci Nurs; 2000 Aug; 32(4):234-8. PubMed ID: 10994538
[TBL] [Abstract][Full Text] [Related]
16. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
[TBL] [Abstract][Full Text] [Related]
17. Drug addiction and brain targets: from preclinical research to pharmacotherapy.
Rahman S
CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):391-2. PubMed ID: 19128198
[No Abstract] [Full Text] [Related]
18. Integrating the neurobiology of schizophrenia. Preface.
Abi-Dargham A; Guillin O
Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
[No Abstract] [Full Text] [Related]
19. Studying monoamine transporters: beyond hypermonoaminaemia.
Reith ME
J Neurosci Methods; 2005 Apr; 143(1):1-2. PubMed ID: 15763131
[No Abstract] [Full Text] [Related]
20. Use of serotonergic agents in the clinical assessment of central serotonin function.
Murphy DL; Mueller EA; Garrick NA; Aulakh CS
J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
